{"id":"ice-t","safety":{"commonSideEffects":[{"rate":"null","effect":"Numbness"},{"rate":"null","effect":"Tingling"},{"rate":"null","effect":"Allergic reactions"}]},"_chembl":{"chemblId":"CHEMBL1697734","moleculeType":"Small molecule","molecularWeight":"227.65"},"_dailymed":{"setId":"ea23616f-1d59-4e32-88bb-d035af727728","title":"SUGARGIRL SUN GLOSS SPF 15 TINTED LIP GLOSS SUNSCREEN PINK ICE (HOMOSALATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE) LIQUID [I WORLD LLC]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by blocking nerve impulses, thereby reducing pain and discomfort. Ice T is often used in medical settings to provide temporary pain relief.","oneSentence":"Ice T is an anesthetic and analgesic agent.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:23:14.824Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Local anesthesia for minor surgical procedures"}]},"trialDetails":[{"nctId":"NCT03570892","phase":"PHASE3","title":"Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2019-05-07","conditions":"Non-Hodgkin Lymphoma","enrollment":331},{"nctId":"NCT05991388","phase":"PHASE2, PHASE3","title":"A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma","status":"RECRUITING","sponsor":"University of Birmingham","startDate":"2024-05-02","conditions":"B-cell Non Hodgkin Lymphoma","enrollment":210},{"nctId":"NCT06676735","phase":"NA","title":"Research on Intraoperative Hypothermia Risk Prediction Model and Temperature Management Strategy for Elderly Patients During Surgery Based on Dynamic Incremental Training","status":"COMPLETED","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2025-03-11","conditions":"Intraoperative Hypothermia","enrollment":1323},{"nctId":"NCT05464329","phase":"PHASE1","title":"Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2023-01-03","conditions":"Large B-cell Lymphoma, High-grade B-cell Lymphoma, Transformed B-Cell Lymphoma","enrollment":24},{"nctId":"NCT04425070","phase":"PHASE1, PHASE2","title":"A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma","status":"TERMINATED","sponsor":"Antengene Corporation","startDate":"2020-08-18","conditions":"Peripheral T-cell Lymphoma, NK/T-cell Lymphoma","enrollment":56},{"nctId":"NCT06931197","phase":"NA","title":"Why Wait? Initiating Contingency Management in Traumatically Injured Patients During Hospitalization","status":"NOT_YET_RECRUITING","sponsor":"Queen's Medical Center","startDate":"2026-01-01","conditions":"Contingency Management, Methamphetamine Use Disorder","enrollment":20},{"nctId":"NCT05364424","phase":"PHASE1","title":"A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2022-11-04","conditions":"Diffuse Large B-Cell Lymphoma (DLBCL)","enrollment":43},{"nctId":"NCT03391466","phase":"PHASE3","title":"Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma","status":"COMPLETED","sponsor":"Kite, A Gilead Company","startDate":"2018-01-25","conditions":"Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)","enrollment":359},{"nctId":"NCT05108805","phase":"PHASE4","title":"Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting","status":"COMPLETED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2021-12-02","conditions":"Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma","enrollment":25},{"nctId":"NCT03987022","phase":"PHASE4","title":"ICE-T Pain Regimen for Total Laparoscopic Hysterectomy","status":"COMPLETED","sponsor":"MetroHealth Medical Center","startDate":"2019-08-01","conditions":"Opioid Substitution Treatment","enrollment":66},{"nctId":"NCT05221645","phase":"PHASE2","title":"Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southampton","startDate":"2022-06-27","conditions":"Diffuse Large B Cell Lymphoma","enrollment":65},{"nctId":"NCT04137770","phase":"NA","title":"Application of the ICE-T Postoperative Multimodal Pain Regimen to Laparoscopic Hysterectomy","status":"TERMINATED","sponsor":"Mercy Research","startDate":"2020-02-04","conditions":"Pain, Postoperative","enrollment":18},{"nctId":"NCT06701487","phase":"","title":"Role of Pavlovian Mechanisms for Control Over Substance Use","status":"RECRUITING","sponsor":"Technische Universität Dresden","startDate":"2024-08-05","conditions":"Alcohol Use Disorder (AUD), Alcoholism, Substance Use Disorders","enrollment":200},{"nctId":"NCT06302556","phase":"","title":"The Role of Immune Checkpoints in Lung Transplant (ILTRA)","status":"UNKNOWN","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2024-04","conditions":"Lung Transplant Rejection","enrollment":280},{"nctId":"NCT05700630","phase":"PHASE1","title":"Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia","status":"WITHDRAWN","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-07-15","conditions":"HIV-1-infection, ART, Cd4+ Lymphocyte Deficiency","enrollment":""},{"nctId":"NCT04789252","phase":"","title":"Heterogeneity of Dendritic Cells in Colon and Non-small Cell Lung Cancer","status":"UNKNOWN","sponsor":"University of Milano Bicocca","startDate":"2021-02-09","conditions":"Non-small Cell Lung Cancer","enrollment":64},{"nctId":"NCT05897333","phase":"","title":"Turkish Isolated Coronary Ectasia Registry: The T-ICE Registry","status":"RECRUITING","sponsor":"Gazi University","startDate":"2022-03-15","conditions":"Coronary Artery Disease","enrollment":3000},{"nctId":"NCT03052816","phase":"PHASE4","title":"Ice T Postoperative Multimodal Pain Regimen in FPMRS Surgery","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2017-04-01","conditions":"Pain, Postoperative, Pelvic Organ Prolapse","enrollment":66},{"nctId":"NCT01154439","phase":"PHASE1","title":"Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Gruppo Italiano Malattie EMatologiche dell'Adulto","startDate":"2010-10","conditions":"Leukemia","enrollment":11},{"nctId":"NCT03212937","phase":"PHASE1","title":"Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma","status":"COMPLETED","sponsor":"National Cancer Centre, Singapore","startDate":"2016-07-01","conditions":"Peripheral T-cell Lymphoma","enrollment":11},{"nctId":"NCT00598169","phase":"PHASE1","title":"Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"AIDS Malignancy Consortium","startDate":"2007-11","conditions":"Lymphoma","enrollment":23},{"nctId":"NCT01590732","phase":"PHASE1","title":"Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-10-29","conditions":"Mycosis Fungoides, Recurrent Anaplastic Large Cell Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma","enrollment":22},{"nctId":"NCT02961816","phase":"PHASE2","title":"Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-06","conditions":"Lymphoma","enrollment":""},{"nctId":"NCT02856997","phase":"PHASE2","title":"Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma","status":"UNKNOWN","sponsor":"Yuankai Shi","startDate":"2016-09","conditions":"Peripheral T Cell Lymphoma","enrollment":35},{"nctId":"NCT00020722","phase":"PHASE2","title":"Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer","status":"TERMINATED","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"2007-08","conditions":"Breast Cancer","enrollment":7},{"nctId":"NCT00604695","phase":"PHASE2","title":"A Safety/Efficacy Study of Intra-coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks","status":"COMPLETED","sponsor":"C. Michael Gibson, MS, MD","startDate":"2008-07","conditions":"Acute Myocardial Infarction","enrollment":40},{"nctId":"NCT00052299","phase":"PHASE3","title":"Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2002-09","conditions":"Leukemia","enrollment":472},{"nctId":"NCT01273701","phase":"NA","title":"Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2011-01","conditions":"Amphetamine Abuse, Amphetamine Dependence, Methamphetamine Abuse","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":32,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ice T","genericName":"Ice T","companyName":"University Hospitals Cleveland Medical Center","companyId":"university-hospitals-cleveland-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ice T is an anesthetic and analgesic agent. Used for Local anesthesia for minor surgical procedures.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}